Post-Marketing Surveillance for Crohn's Disease Patients Treated With STELARA
Post-Marketing Surveillance for Crohn's Disease Patients Treated With STELARA
The purpose of post-marketing surveillance (PMS) is to assess the safety and effectiveness of ustekinumab (Stelara) for Crohn's disease participants under real world clinical practice.
Inclusion Criteria:
Exclusion Criteria:
- Have contraindication to Stelara in accordance to the label
Changwonsi, 51472, South Korea
Cheonan-si, 31116, South Korea
Kyunggido, South Korea